ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Q1 2025 Earnings Call Transcript

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Q1 2025 Earnings Call Transcript May 14, 2025

ARS Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS is $-0.35 EPS, expectations were $-0.35.

Operator: Good morning and welcome to ARS Pharmaceuticals’ Conference Call. At this time, all participants are in listen-only mode. After the company’s prepared remarks, we will open the lines for questions. Please be advised that today’s conference is being recorded. I would now turn...